Cancer Prevention News

Each year, the first Friday in March kicks off Colorectal Cancer Awareness Month with National Dress in Blue Day, a campaign aimed at increasing visibility, raising awareness and honoring those impacted by this highly preventable disease.

In this Healio video, Rasmi Nair, MBBS, MPH, PhD, reports findings from a recent study, which showed 10% of at-home fecal immunological tests for colorectal cancer screening could not be processed, mostly due to specimen errors.

More than one-third of children aged 9 to 17 years in the United States had received one or more HPV vaccines doses as of 2022, according to a new CDC report.

The FDA granted 510(k) clearance to Cyted’s EndoSign, a non-endoscopic capsule sponge device intended to gather pan-esophageal samples for early detection of esophageal cancer as well as other conditions, according to a company release.

Considering conflicting clinical guidelines, primary care providers should focus on individualized decision-making when deciding if and when a patient should be screened for breast cancer, according to experts.

As the broader health care field strives to identify and address health care disparities, a commentary published in The Lancet Oncology underscored the importance of eliminating ableism from cancer care.

The FDA has granted breakthrough device designation to Amadix’s PreveCol, a blood test for early detection of colorectal cancer, intended to screen adults aged 45 years or older without apparent symptoms, according to a company release.

Patients diagnosed with cryptogenic pyogenic liver abscess had a “significantly higher incidence” of colorectal cancer up to 3 years from diagnosis compared with matched controls, highlighting the importance of CRC screening, data showed.

Oncologists were satisfied with an electronic system for consulting with allergists about hypersensitivity reactions during chemotherapy, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

In this episode, host Shikha Jain, MD, speaks with Erica Barnell, MD, PhD, about Geneoscopy’s non-invasive screening and early detection technology, helping improve patient compliance for gastrointestinal health and more.